Qualification Honor

Patent status (B, C and t indicate authorization)
Ivabradine HCl: 

The invention relates to a stable crystal form of ivabradine hydrochloride and a preparation method thereof cn101284813b,  
Ivabradine hydrochloride and its preparation method cn101353325b
Ulipristal Acetate: 

Stable Ulinastatin acetate crystal form and preparation method thereof：CN102675395B，CN103755765A， 
Process patent：
Preparation method of ulinastatin acetate and its intermediate 
AU2012331996 (A1)   AU2012331996 (B2)   BR112014010263 (A2)   CA2851399 (A1)   CN102516345 (A)  CN102516345 (B)   EP2774933 (A1)   EP2774933 (A4)   EP2774933 (B1)   ES2669052 (T3)  IN2562CHN2014 (A)   JP2014528459 (A)   JP5913599 (B2)   MX2014005245 (A)   MX343774 (B)  PL2774933 (T3)  HUE037674 (T2) RU2014120908 (A)   RU2624007 (C2)   US2014296510 (A1)   US9163058 (B2)  WO2013063859 (A1)  
Apremilast: 

Process patent：
Preparation of alprostat and its intermediates
CN201410335852.6
Crystal form patent：
Stable alprostat crystal form II without solvate and preparation method thereof
AU2015385707 (A1)   AU2015385707 (B2)   CN104761484 (A)   CN104761484 (B)   EP3269711 (A1)  EP3269711 (A4)   EP3269711 (B1)   JP2018501317 (A)   JP6457658 (B2)   US2017298018 (A1)  US9850205 (B2)   RU2673889 (C1)   WO2016141503 (A1) 

High tech enterprise certificate：